Figures
Abstract
Anthelmintic drugs are used to control soil-transmitted helminths that infect a quarter of the world’s human population. There is increasing concern about the development of resistance to anthelmintic drugs because of the limited number of compounds available and there is an unmet need for new resistance-busting drugs. Here we describe the presence of a previously unrecognized endogenous acetylcholine (ACh) analogue, β-alanine betaine, which may serve as an endogenous ligand for an alternate subfamily of nicotinic receptors (DEG-3/DES-2) that could be developed as novel drug targets because their analogues are not present in their human or animal hosts. We collected pseudocoelomic fluid from female Ascaris suum (a model for the human parasite Ascaris lumbricoides) and subjected it to HILIC-MS and HILIC-MS/MS to reveal signals consistent with ACh, choline, and β-alanine betaine but not betaine, propionylcholine, butyrylcholine, or butyrobetaine. The presence of β-alanine betaine was confirmed by comparison with an analytical standard. Injection of betaine into female A. suum produced no effect. However, injection of β-alanine betaine produced characteristic pretzel coiling and injection of levamisole produced a rod-like spastic paralysis. The differences between β-alanine betaine and levamisole suggested that they activate different nAChRs subfamilies. RT-PCR showed that message for members of the DEG-3/DES-2 subfamily of nAChR channels, which are betaine targets, were present in the intestine and body wall of A. suum. β-alanine betaine increased intracellular Ca2+ of the intestinal enterocytes and depolarized the membrane potential of body wall muscle cells. In N2 Caenorhabditis elegans, application of β-alanine betaine produced gradual inhibition of motility, which was reduced in acr-20, acr-23, deg-3/des-2 and lgc-41 null-mutants. These observations suggest that, in addition to ACh, β-alanine betaine - an analog of betaine produced under anaerobic conditions - may function as an endogenous ligand in anaerobic nematodes such as A. suum. An expanded repertoire of nicotinic acetylcholine receptor subfamilies in nematodes relative to mammals may reflect a corresponding need for diversification of cholinergic endogenous ligands in these organisms. This repertoire could allow their simpler neuronal system to perform more complex controls and be exploited for development of different and novel subfamily selective cholinergic anthelmintics.
Author summary
There is increasing concern about the development of resistance to anthelmintic drugs because of the limited number of compounds available and there is an unmet need for new resistance-busting drugs. The cholinergic anthelmintics are one of the three major classes of anti-nematodal drugs that are used for control and treatment of soil-transmitted helminths. Each of these cholinergic anthelmintics (levamisole, pyrantel, derquantel, monepantel and oxantel) are selective for different nematode nicotinic acetylcholine receptors (nAChRs). The differences in selectivity could explain why resistance and species sensitivities varies across the different cholinergic anthelmintics. It is surprising how many nAChR genes are expressed in nematodes with more being present compared to humans. Why is this? Could it be that there are also more endogenous ligands other than ACh allowing their simpler neuronal system to perform more complex control? We looked for additional analogues of ACh in the body fluid of the large intestinal pig parasite, Ascaris suum, (a model for Ascaris lumbricoides) and identified the anaerobic cholinergic compound β-alanine betaine. We found evidence that suggests that β-alanine betaine may serve as an endogenous ligand for an alternate subfamily of nicotinic receptors (DEG-3/DES-2) that could be developed as novel drug targets because their receptor analogues are not present in human or animal hosts.
Citation: Williams PDE, Borts DJ, Liu D, Byerley-Duke J, VanVeller B, Martin RJ (2026) A novel anaerobic cholinergic signaling compound, β-alanine betaine, and nAChRs in Ascaris. PLoS Negl Trop Dis 20(9): e0014518. https://doi.org/10.1371/journal.pntd.0014518
Editor: Bruce A. Rosa, Washington University in St Louis School of Medicine, UNITED STATES OF AMERICA
Received: June 29, 2026; Accepted: August 20, 2026; Published: September 8, 2026
Copyright: © 2026 Williams et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The minimal data set is available at https://doi.org/10.25380/iastate.32806229.
Funding: This study was supported by NIH NIAID Grants R01AI047194, R01AI155413, to RJM, the EA Benbrook Endowed Chair of Pathology and Parasitology and by ISU CVM Seed Grant funding from the Dr Stephen G. Juelsgaard Dean’s award to PDW from Iowa State College of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PDW received salary from the R01AI155413, NIH NIAID Grant.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Soil transmitted helminths are common world-wide and affect 1.5 billion people [1]. Nematodes possess a large and diverse repertoire of nicotinic acetylcholine receptor (nAChR) subunit genes. In C. elegans, for example, ~ 32 annotated subunit genes have been classified into the UNC-29, UNC-38, ACR-8, ACR-16 and DEG-3/DES-2 subfamilies [2]. In addition, ~ 25 orphan nAChR-like subunit genes do not fall into any of these five core groups. In parasitic nematodes there are similar groupings of nAChRs and many subunit genes [3].
The cholinergic anthelmintics are one of three major groups of drugs used to treat soil-transmitted helminth infections. Each of the cholinergic anthelmintics (levamisole, pyrantel, derquantel, monepantel and oxantel) are selective for different nematode nAChRs that are each composed of different nAChR subunits [4,5]. Of interest here is the DEG-3/DES-2 subfamily of nAChRs which in C. elegans includes ACR-5, ACR-17, ACR-18, ACR-20, ACR-23, ACR-24, DES-2, and DEG-3 subunits. Interest in the DEG-3/DES-2 family increased with the discovery of the anthelmintic monepantel, which modulates ACR-23 and ACR-20 subunits in C. elegans and MPTL-1 (Hc-ACR-23H) subunits in Haemonchus contortus [6–8]. Betaine and choline are endogenous nAChR ligands in C. elegans that are agonists of ACR-20, ACR-23 and DEG-3/DES-2 nAChRs as well as the betaine gated chloride channel LGC-41 [7–10]. It is not known if there are additional endogenous cholinergic ligands in addition to acetylcholine (ACh) in parasitic nematodes.
We collected and analyzed constituents of Ascaris suum pseudocoelomic fluid to identify additional cholinergic ligands using hydrophilic interaction liquid chromatography coupled to full mass range (HILIC-MS) and found signals consistent with the presence of ACh, choline and β-alanine betaine but not betaine. We confirmed the presence of choline and β-alanine betaine using HILIC-MS/MS. Subsequent PCR experiments found multiple members of the DEG-3/DES-2 subfamily of nAChR subunits are present in the intestine and body wall of A. suum. Intestine calcium signaling experiments and muscle bag electrophysiology found that β-alanine betaine increased enterocyte Ca2+ and depolarized the body muscle. The paralytic effect of β-alanine betaine was not restricted to just parasitic nematodes as C. elegans became paralyzed when exposed to plates containing the compound, which was reduced in nulls for different members of the DEG-3/DES-2 superfamily. These observations together suggest that in addition to ACh, β-alanine betaine rather than betaine in the anaerobic nematode parasite may serve as an endogenous ligand and promote paralysis unlike the aerobic compound betaine. This large number of nAChR subunit genes found in nematodes and endogenous ligands compared to mammals may allow the simpler neuronal system of nematodes more complex control. The DEG-3/DES-2 superfamily of nAChRs is a distinctive group of ligand gated ion-channels that may be developed further as anthelmintic drug targets.
Methods
Collection and maintenance of A. suum worms
Adult female A. suum worms were collected from the JBS Swift and Co. pork processing plant at Marshalltown, IA, and were maintained in Ascaris Ringers Solution (ARS: 13 mM NaCl, 9 mM CaCl2, 7 mM MgCl2, 12 mM C4H11NO3/ Tris, 99 mM Na acetate, 19 mM KCl and 5 mM glucose pH 7.8) at 32°C for 24 hrs. to allow for acclimatization before use in experiments. The solution was changed twice daily, and worms were used within three days of collection for experiments. All worms were examined at the start of each day and were excluded if they were damaged or became immotile.
Injection of compounds into Ascaris suum
Healthy and motile A. suum were selected and placed in a dissection tray filled with warmed ARS. Worms were left to acclimatize in the tray for two mins and were monitored for movement. All solutions were prepared in Ascaris Perienteric Fluid APF (23 mM NaCl, 110 mM Na acetate, 24 mM KCl, 6 mM CaCl2, 5 mM MgCl2, 5 mM HEPES, 11 mM D-glucose, pH 7.6 using NaOH or acetic acid). Worms were injected with either 500 µL APF (negative control), 500 µL 30 µM levamisole (positive control), 500 µL 30 µM betaine or 500 µL 30 µm β-alanine betaine. Solutions were injected into the worm above the collar using a 23-gauge needle attached to a 1 mL Luer slip syringe. Worms were monitored for 2 mins and were assessed for paralysis.
A. suum cDNA synthesis and RT-PCR detection of DEG-3/DES-2 nAChR superfamily members and Sanger sequencing
A. suum orthologues of the DEG-3/DES-2 family members and LGC-41 were identified by blasting the C. elegans protein and cDNA sequences for each target, obtained from WormBase (www.wormbase.org ver. WS298), against the A. suum genome (PRJNA62057) found on WormBase Parasite (parasite.wormbase.org ver. WS291). The identified orthologues for each gene and the accession number for ENA depository are presented in Table 2.
The A. suum intestine was separated from the body wall, which includes muscles, muscle bags and nerves, and both tissues were homogenized separately in 1 mL of Trizol reagent using a mortar and pestle, followed by total RNA extraction according to the Trizol Reagent protocol (Life Technologies, Waltham, MA, USA). One microgram of total RNA from each tissue was used to generate cDNA by reverse transcription (RT) using SuperScript VILO Master Mix (Life Technologies, Waltham, MA, USA) following the manufacturer’s protocol. RT-PCR was conducted to detect the presence of Asu-acr-20, Asu-acr-23, Asu-deg-3, Asu-des-2, and Asu-lgc-41 using primers targeting coding regions of each gene (Table 1). Asu-gapdh was used as a reference gene. Negative controls included enzyme, water, and both forward and reverse primers for the target with no cDNA template. The cycling conditions for PCR were an initial denaturation for 2 min at 95 °C, followed by 35 cycles of 95 °C for 30 sec, 60 °C for 35 sec, 72 °C for 45 sec, and a final extension at 72 °C for 10 min using GoTaq G2 Hot Start Green Master Mix (Promega, USA). PCR products were separated on a 2% agarose gel containing SYBR Safe DNA Gel Stain (Invitrogen, Waltham, MA, USA) followed by visualization and images were captured using an Azure 600 imaging system (Azure Biosystems, Dublin, CA, USA) set to SYBR Safe (excitation 472 nm, emission 595 nm). Uncropped and unedited raw images are shown in S1 Raw gel.
Amplification of full-length Asu-acr-23 was performed using Platinum SuperFi II Green PCR Master Mix (Thermo Fisher Scientific, Waltham, MA, USA) under the following conditions: 98 °C 30s; 35 cycles at 98 °C 30 s, 60 °C for 20 s, 72 °C for 30 s and a final extension at 72 °C for 10 mins. Products were visually identified on a 1% agarose gel containing SYBR Safe as previously described. Target bands were excised and purified with the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel, Düren, Germany) per the manufacturer’s instructions. Purified amplicons were submitted to the Iowa State University DNA Sequencing Facility for Sanger sequencing (bidirectional reads were achieved using the forward and reverse primers provided in Table 1). The full-length sequencing result is provided in S4 Fig.
C. elegans strains and maintenance
C. elegans strains were maintained on NGM agar plates seeded with E. coli OP50 bacteria per standard protocols [11]. Strains used were: N2, RB2119 acr-23(ok2804) V, VC1598 acr-20(ok1849)/mT1 II; + /mT1 [dpy-10(e128)] III, TU1803 deg-3(u662); des-2(u695) V and PS8729 lgc-41(sy1494) X. All strains were acquired from the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN, USA).
Ascaris suum muscle flaps for electrophysiology
1 cm muscle tissue flaps were prepared by dissecting the anterior part of the worm, 2–3 cm caudal to the head. A body muscle flap preparation was then pinned onto a Sylgard-lined double jacketed bath chamber maintained at 35 ˚C by inner circulation of warm water using a 6-liter circulating Isotemp3016H water bath (Fisher scientific, Waltham, MA, USA). The intestine was removed to expose the muscle cells [12]. The preparation was continuously perfused, unless otherwise stated, with APF. The incoming perfusate was pre-warmed to 35˚C with an SH 27B in-line heating system (Warner Instruments, Holliston, MA, USA) before it was perfused at 3.5-4 mL/min through a 20-gauge (1.5″ long) needle placed directly over the muscle bag. Stocks of the experimental compounds were dissolved in APF. Concentrations of 30 µM, 100 µM, 300 µM and 1 mM β-alanine betaine were applied for a period of 10 secs by means of a tube that rapidly replaced all the bathing solution covering the Ascaris muscle cells. Flanking applications of 10 µM ACh were applied at the start and end of each recording for 10 secs to determine viability.
A single micropipette was used to record the membrane potential and to examine the electrophysiological effects in the A. suum muscle bag region. Borosilicate capillary glass (Harvard Apparatus, Holliston, MA, USA, ID-0.86mm, OD- 1.5mm) micropipettes were pulled on a Flaming Brown Micropipette puller (Sutter Instrument Co., Novato, CA, USA) and filled with 3 M potassium acetate (resistance 20–30 MΩ). The recordings were obtained by impaling the bag region of A. suum muscle with both the micropipettes. All experiments were performed using an Axoclamp 2A amplifier, a 1320A Digidata interface and Clampex 9 software (Molecular Devices, San Jose, CA, USA).
C. elegans paralysis assays
Motility responses to β-alanine betaine were assayed on NGM plates that were prepared four hours before the experiment. 50 mM β-alanine betaine was added to molten agar (~55°C). Once solidified, fresh E. coli OP50 was added to the plates, which were left to air dry (~ 2 hrs.). 20–40 L4 animals were picked the night before the assay onto fresh OP50 seeded NGM plates and left to develop to young adults overnight at room temperature. Animals were transferred from the stock plate to an intermediate plate for one minute to allow animals to separate and be assessed for motility. Ten suitable animals were transferred to β-alanine betaine assay plates and motility was measured. Worms that either appeared damaged or had reduced movement or no movement were removed from the assay plate and replaced with viable C. elegans. Animals were allowed to free roam on the bacterial lawn and were assessed after 10, 20, 30, 45, 60, 90 and 120 mins. Animals were scored based on movement by lightly tapping the ‘nose’ of the worm with a hair. If the worm failed to respond to the hair, they were considered paralyzed.
Preparation and loading Fluo-3AM
A 2 cm section of the A. suum intestine was removed from the body piece using fine forceps and cut open. The intestinal flap was placed into a laminar flow recording chamber (RC-26) which was secured on top of a coverslip (24 x 50 mm) in a PH-1 heated platform and pinned using a slice anchor (26 x 1mm x 1.5mm grid) (Warner Instruments, Holliston, MA, USA). The sample was immersed in 1 mM CaCl2 APF (23 mM NaCl, 110 mM Na acetate, 24 mM KCl, 1 mM CaCl2, 5 mM MgCl2, 5 mM HEPES, 11 mM D-glucose; pH 7.6). Fluo-3AM (Sigma-Aldrich, St. Louis, MO, USA) loading was achieved by incubating the tissue in Ca2+-free (<100 µM) APF containing 5 µM Fluo-3AM and 0.05% Pluronic F-127 (10% v/v in water; Invitrogen, Waltham, MA, USA) for 60 mins with the recording chamber connected to a Dual Automatic Temperature Controller (Warner Instruments, Holliston, MA, USA) maintained at 36–37°C. After incubation, the Fluo-3AM solution was discarded, and the sample was incubated in 1 mM CaCl2 APF for an additional 20 mins at 36–37°C to promote Ca2+ loading. Fluo-3AM loading was confirmed under blue light using a blue/green filter box (EF-4 AT EGFP/FITC/CY2/ALEXA FLUOR Band Pass; excitation: 465–495 nm, emission: 525–545 nm, dichroic mirror) (Chroma Technology, Bellows Falls, VT, USA) and visualized under pseudo-color settings using MetaFluor 7.10.2 (Molecular Devices, San Jose, CA, USA). Any tissue that did not show Fluo-3 fluorescence was discarded.
Measurement of Ca2+ fluorescence
All recordings were performed on a Nikon Eclipse TE3000 microscope (Nikon, Tokyo, Japan) fitted with a 20X/0.45 Nikon PlanFluor objective, using a PhotoMetrics Retiga R1 Camera (PhotoMetrics, Inc., Huntington Beach, CA, USA). Light control was achieved using a Lambda 10–2 with a shutter controller. Fluorescence was achieved using a Lambda LS Xenon bulb lightbox (Sutter Instruments, Novato, CA, USA) which delivered light via a fiber optic cable to the microscope which passed through the blue/green filter box. Fluorescent light emission was controlled by using the shutter. Minimal illumination exposure was used to prevent photobleaching.
During recordings, tissues were continuously perfused with 1 mM CaCl2 APF. Intestinal preparations were exposed to 1 mM β-alanine betaine for five mins. Application of 10 mM CaCl2, which was used as a positive control to determine tissue viability, was applied 5 mins after the β-alanine betaine signal returned to baseline to detect delayed or latent responses to occur. Every experiment reported in this study had a 100% response to 10 mM CaCl2. A change in fluorescence ≥5% was classified as a positive response to a compound as the mean spontaneous change in cells continuously perfused with APF buffer was ~ 2.5% [13]. Stocks and working concentrations of all compounds were made in 1 mM CaCl2 APF buffer solution.
All solutions were delivered to the chamber under gravity feed through solenoid valves controlled using a VC-6 six-channel valve controller through an inline heater set at 37°C (Warner Instruments, Holliston, MA, USA), at a rate of 1.5mL/min. At the start of all experiments, intestinal preparations were left under blue light for a minimum of 3 mins to promote settling and equilibration of the fluorescent signal and to monitor spontaneous Ca2+ signals.
All Ca2+ signal recordings were acquired and analyzed using MetaFluor 7.10.2 with exposure settings at 250 ms with 2x binning. Ca2+ signals from each intestine were collected from 50 square 50 µm x 50 µm areas across the intestine covering a total area of 125,000 µM2 that included 800–1000 individual enterocytes. The mean fluorescence amplitude was calculated for each intestinal exposure of all 50 regions. Maximal percent Ca2+ signal amplitudes (ΔF) were calculated using the equation F1-F0/F0 x 100, where F1 is the fluorescent value and F0 is the baseline value. All F0 values were taken at the time point each compound was applied for every region analyzed. All representative response traces are presented as the mean percent change in Ca2+ fluorescence with the standard error of the mean (±SEM) of all regions from a single recording. Traces were generated by converting the Ca2+ signal profiles of all the regions from a single recording to percentages using the previously described ΔF/F0 equation, with the time of stimulus application being F0 (0% for all regions) and 100% being the peak value for each region. The number of intestinal tissues recorded (n), along with the total number regional responses are provided in the figure legends.
Determination of choline analogues by HILIC–MS and HILIC–MS/MS
2.5 mL A. suum pseudocoelomic fluid samples were acquired from freshly collected worms and 20 µM neostigmine was added as an esterase inhibitor to reduce the hydrolysis of acetylcholine. Choline analogues in A. suum pseudocoelomic fluid were initially identified using hydrophilic interaction liquid chromatography coupled to full mass range (HILIC-MS). The presence of choline and β-alanine betaine were then confirmed using tandem mass spectrometry (HILIC–MS/MS).
Sample preparation
Fluid samples were maintained on ice and mixed thoroughly. Proteins were precipitated by adding three volumes of ice-cold acetonitrile. Samples were vortexed for 30 s and incubated on ice for 10 min. The mixture was centrifuged at 15,000 × g for 10 min at 4 °C. The supernatant was transferred to autosampler vials and diluted with acetonitrile to achieve 80–90% organic solvent prior to injection.
HILIC chromatography
Chromatographic separation was performed using a Thermo Fisher Scientific Vanquish Flex UHPLC system with a HILIC column (Agilent Infinity Lab Poroshell 120 HILIC-Z; 2.1 x 100 mm, 2.7 µm particle size) maintained at 30 °C. The mobile phases consisted of: A: 95:5 water/acetonitrile with 10 mM ammonium acetate and mobile phase and; B: 95:5 acetonitrile/water with 10 mM ammonium acetate. The gradient started at 90% B, ramped linearly to 50% B over 5 mins, then from 50% B to 40% B over 1 min, held for 2 mins at 40% B, then returned to initial conditions over 1 min, and equilibrated for 6 mins. The flow rate was 0.3 mL/min, and the injection volume was 10 µL.
Mass spectrometry
Detection was performed using a Thermo Fisher Scientific Exploris 120 quadrupole-orbitrap mass spectrometer equipped with an electrospray ionization (ESI) source operated in positive ion mode. The following source parameters were used: capillary voltage 3.5 kV, sheath gas = 50 (Arb), aux gas = 10 (Arb), sweep gas = 1 (Arb), ion transfer tube temp = 325 °C, vaporizer temp = 350 °C.
Additional mass spectrometer settings include: full mass range resolution = 60,000, MS/MS resolution = 15,000, full mass range = 50 – 500 m/z, MS/MS mass range was set to “auto”, Automatic Gain Control (AGC) was set to ‘standard’ for both full mass range and MS/MS, and maximum ion time was set to ‘auto’ for both full mass range and MS/MS. MS/MS data was acquired in t-MS2 (targeted MS2) mode.
Statistical analysis
Statistical analysis of all data was done using GraphPad Prism 9.0 (GraphPad Software, Inc., La Jolla, CA, USA). To ensure reproducibility, we repeated our experiments: the numbers of animals, number of preparations, the concentrations, and durations of applications are provided in the legends of the figures. Analysis of changes in depolarization was done using paired or unpaired student t-tests with P < 0.05 being considered significant. All data are presented as mean ± SEM for each treatment.
Chemicals
Source of chemicals: β-alanine betaine was produced by ISU and characterization matched previous reports [14]. For the mass spectrometry experiments, the β-alanine betaine neat chemical standard was purchased from Smolecule (San Antonio, TX, USA), and both ACh and choline standards were purchased from Sigma-Aldrich (Burlington, MA, USA). Betaine was supplied by Spectrum Chemicals (New Brunswick, NJ, USA) and levamisole was provided by MP biomedicals (Santa Ana, CA, USA). Fisher Scientific supplied all other chemicals.
Results
Collection of pseudocoelomic fluid and identification of β-alanine betaine
We describe here observations that suggest that β-alanine betaine (Fig 1) may be an additional endogenous cholinergic ligand in Ascaris suum. The pseudocoelomic fluid of A. suum is a protein rich, metabolically active fluid that distributes metabolites and nutrients along the length of the nematode. This fluid is found between the intestine and cuticle of the worm bathing the muscle and nerves. ACh has already been found to be present in A. suum pseudocoelomic fluid [15]. To determine if other cholinergic transmitters are present in the pseudocoelomic fluid, we dissected adult female A. suum (N = 4) and drained the fluid from the parasite. We added 20 µM neostigmine to inhibit esterases that could degrade cholinergic compounds in the fluid.
The fluid was analyzed using Liquid Chromatography-Mass Spectrometry (HILIC-MS). We observed signals consistent with ACh (S1 Fig) choline, and β-alanine betaine but did not observe evidence of betaine, propionylcholine, butyrylcholine or, butyrobetaine. ACh, synthesized from choline, is the principal excitatory neurotransmitter in nematodes and is extensively characterized through biochemical and electrophysiological studies. Choline has been identified previously in the nematodes C. elegans [16]; Necator americanus and Nippostrongylus brasiliensis [17]. Betaine has been identified previously in C. elegans [18]; H. contortus [19]; N. Americanus; and N. brasiliensis [17,20]. We confirmed with HILIC-MS/MS the presence of choline (S2 Fig) but did not find evidence of betaine in A. suum. Interestingly, we detected in the pseudocoelomic fluid of A. suum an unknown compound with a retention time of 3.39 min (Fig 2A). After further analysis, the compound was hypothesized to be β-alanine betaine (Fig 1).
A: Chromatogram from A. suum pseudocoelomic fluid for suspected β-alanine betaine. B: Chromatogram for β-alanine betaine neat chemical standard. C: MS/MS spectrum for suspected β-alanine betaine from A. suum pseudocoelomic fluid. D: MS/MS spectrum for β-alanine betaine neat chemical standard.
To verify that the unknown compound was β-alanine betaine, a standard was purchased from Smolecule, and analysis with HILIC-MS/MS was performed. The β-alanine betaine standard matched the profile of the presumed β-alanine betaine from the pseudocoelomic fluid with an identical retention time of 3.39 min (Fig 2B), and Tandem Mass Spectrometry peaks at 58.06, 59.07, 60.08, 73.03, and 132.10 m/z (Fig 2C and 2D). Signals consistent with β-alanine betaine were observed in all four samples.
Pretzel effect of injected β-alanine betaine
With the detection of β-alanine betaine in the A. suum pseudocoelomic fluid, we investigated if this compound modulates motility like other cholinergic compounds. We injected either 500 µL of APF salt solution (negative control: N = 4), 500 µL 30 µM levamisole (positive control: N = 4), 500 µL 30 µM betaine (N = 4), or 500 µL 30 µM β-alanine betaine (N = 4), into separate free moving adult female A. suum using a fine needle, just in front of the gonopore and compared the effects on motility. The APF injection did not affect the continuous slow movement of any of the worms or their posture (Fig 3A). The injection of levamisole rapidly inhibited movement and all worms straightened into rod-like structures (Fig 3B). The injection of betaine, like APF, did not affect the slow movement or posture of the worms (Fig 3C). However, the effect of β-alanine betaine was different to the other compounds as all worms slowly became coiled and formed a ‘pretzel’ like structure (Fig 3D). These results demonstrate that β-alanine betaine promotes a unique paralytic phenotype in A. suum, potentially by acting on cholinergic receptors.
A: Adult female A. suum injected with 0.5mL APF, the worm continued to move with no clear effect, n = 4. B: Adult female A. suum injected with 0.5mL 30 µm levamisole: note the straight rod paralyzed appearance, n = 4. C: Adult female A. suum injected with 0.5mL 30 µm betaine: the worm continued to move with no striking effects, n = 4.D: Adult female A. suum injected with 0.5mL 30 µm β-alanine betaine. Note the coiling (pretzel) posture, n = 4.
DEG-3/DES-2 subfamily subunits, including ACR-23, are present in Ascaris intestine and body wall
The different effects of injected levamisole and β-alanine betaine on A. suum paralysis suggests the two compounds act at different sites. Levamisole activates nAChRs which are composed of UNC-29, UNC-63, ACR-8, UNC-38 subunits which are not part of the DEG-3/DES-2 subfamily [2,21]. In C. elegans, betaine is an agonist of either homomeric nAChRs composed of ACR-23 or ACR-20 [7,8,22], DEG-3/DES-2 heteromeric receptors [9], or the betaine-gated chloride channel LGC-41 [10], suggesting that β-alanine betaine could act on similar receptors in A. suum.
In C. elegans, ACR-23 is expressed in different tissues, including body wall muscles [23]. To determine if acr-23 is present in A. suum, we performed a blast search with Cel-acr-23 (F59B1.9) against the A. suum genome (PRJNA62057) and identified the gene AgR001_g108, as the Asu-acr-23 orthologue with 53.6% similarity in the protein sequence to Cel-ACR-23 (S3 Fig). We generated primers targeting Asu-acr-23 (Table 1) and screened for the presence in paired cDNA pools of intestine and body wall (the body wall includes the muscle and nerve cords). Asu-acr-23 is present in both cDNA pools (Fig 4 and S1 Raw gel). To ensure that we successfully targeted Asu-acr-23 we performed Sanger sequencing by comparing the full length acr-23 product obtained from our cDNA pool against the AgR001_g108 sequence found in the WormBase Parasite database. Our full-length Asu-acr-23 was 99.8% similar to the database (S4 Fig).
A: paired body wall. B: intestine from female A. suum. Each lane represents one of the genes for the intestine or body wall of an individual worm. Asu-gapdh from the intestine or body wall was used as a positive control (Cb/Ci). NC = negative control, no cDNA template present. M = FastRuler Middle Range DNA Ladder (ThermoFisher Scientific).
We also identified and screened for the presence of A. suum orthologues of the other C. elegans betaine sensitive channels including, ACR-20, DES-2 and DEG-3 and the inhibitory betaine activated ion channel LGC-41 as possible β-alanine betaine targets (Tables 1–2). We detected the presence of all four subunits in both the intestinal and body wall cDNA pools of A. suum (Fig 4 and S1 Raw gel), with Asu-acr-23 having the brightest band visually in the body wall. These results suggest that targets composed of these genes may mediate the effects of β-alanine betaine in A. suum.
Intestine and muscle cells responses to β-alanine betaine
With the identification of potential receptors for β-alanine betaine, we investigated if application to either the intestine or muscle elicited a response. We first tested the effects of β-alanine betaine on the intestine of A. suum by measuring the Ca2+ signal. One mM β-alanine betaine induced large and prolonged increases in enterocyte intracellular Ca2+, with a mean amplitude of 31% ± 2.09% (N = 3) (Fig 5A and 5B). Interestingly, the increase in the Ca2+ signal did not occur immediately after applying β-alanine betaine but instead took 2 minutes before the Ca2+ started to increase (Fig 5A). The Ca2+ signal started to slowly decline after β-alanine betaine was washed out before returning to near baseline levels with 79% ± 8.1% of intestinal regions having an increase in fluorescence (Fig 5C), suggesting that the receptors were not localized to specific regions of the intestine. To test for viability, 10 mM CaCl2 was applied and we observed robust increases in Ca2+ (54% ± 1.8%) in 100% of regions (Fig 5B and 5C).
A: Representative response to 1mM β-alanine betaine. Red lines indicate mean fluorescence; black dotted lines represent ±SEM. Grey Box indicates stimulus application. B: Total mean maximal amplitudes of Ca2+ fluorescence to 1mM β-alanine betaine (grey bar) and 10mM CaCl2 (white bar). C: Mean percent of regions showing a Ca2+ response to 1mM β-alanine betaine (β-alanine betaine: grey bar) and 10mM CaCl2 (white bar). n = 3 intestines from 3 individual female A. suum with 150 total regions. β-alanine betaine 119/150 regions responding, CaCl2 = 150/150 regions responding. All values represented as means ± SEM.
We also measured the effects of β-alanine betaine on the membrane potential of A. suum body muscle cells. We applied 10 sec applications of 30 µM, 100 µM, 300 µM and 1 mM β-alanine betaine to body muscle cells and compared the effects to flanking 10 µM ACh applications (Fig 6). In each of the muscle cell preparations, the depolarization in response to β-alanine betaine was slower and weaker when compared to ACh but demonstrated a concentration dependent effect, with 30 µM β-alanine betaine having an mean ΔmV of 0.06 mV ± 0.03, 100 µM having a ΔmV of 0.4 ± 0.2, 0.3 mM having an mean ΔmV of 1.2 mV ± 0.3 and 1 mM having an mean of 2.2 mV ± 0.4 (Fig 6A and 6B). We observed no significant difference between the flanking 10 µM ACh applications (6.9 mV ± 1.1 and 7.1 mV ± 0.9) (Fig 6B). We also observed a concentration dependent effect on the rate of spontaneous depolarizations (spikes) that took more than a minute before reaching full effect with 1 mM β-alanine betaine having the highest frequency 79.3 spikes min-1 (± 16.4) (Fig 6A and 6C). Again, we observed no significant difference between the flanking 10 µM ACh applications (25.5 ± 5.1 and 25.75 ± 4.1) (Fig 6C). These results demonstrate that β-alanine betaine has effects on A. suum muscle depolarization and intestinal Ca2+ signaling suggesting a novel functional cholinergic ligand in an anerobic parasite.
A: An intracellular membrane potential recording from the muscle bag-region of a female A. suum worm to higher concentrations of β-alanine betaine. Samples were first exposed to an application of 10 µM ACh by rapid perfusion for 10sec followed by an application of 300 µM β-alanine betaine for 10 sec, 1 mM β-alanine betaine for 10 sec and finally to a second application of 10 µM ACh for 10 sec. B: Histograms of the mean + /- S.E.M. peak depolarization responses to the first 10 µM ACh application (grey bar), 30 µM β-alanine betaine, 100 µM β-alanine betaine (green bar), 300 µM β-alanine betaine (blue bar), 1 mM β-alanine betaine (red bar), and the second application of 10 µM ACh (grey bar; hashed). N.S. not significantly different to 1st 10 µM ACh (1st 10 µM ACh vs 2nd ACh, P = 0.799, t = 0.2613, df = 11, paired t-test). C: Histograms of the mean + /- S.E.M. number of spikes produced during the application of first 10 µM ACh application (grey bar), 30 µM β-alanine betaine (pink bar), 100 µM β-alanine betaine (green bar), 300 µM β-alanine betaine (blue bar), 1 mM β-alanine betaine (red bar), and the second application of 10 µM ACh (grey bar; hashed). N.S. not significantly different to 1st 10 µM ACh (1st 10 µM ACh vs 2nd ACh, P = 0.931, t = 0.088, df = 11, paired t-test). ACh recordings n = 12 individual muscles from 12 individual A. suum females. 300 µM and 1 mM β-alanine betaine n = 7 total recordings from 7 individual A. suum females. 100 µM β-alanine betaine n = 5 total recordings from 5 individual A. suum females. 30 µM β-alanine betaine n = 4 total recordings from 4 individual A. suum females. All values represented as means ± SEM.
Effects of β-alanine betaine on DEG-3 C. elegans subfamily null mutants
With evidence that β-alanine betaine affects the movement and produces a pretzel shaped A. suum after injection, we utilized C. elegans to determine if an effect of β-alanine betaine was species specific. Following previous techniques with betaine and using established techniques with C. elegans with high concentrations that are required to cross their cuticle and to overcome bacterial metabolism [24,25], we incubated wild-type N2 C. elegans animals on E. coli OP50 seeded NGM plates containing 50 mM β-alanine betaine. The motility of C. elegans decreased progressively over 2 hours with 77% (± 3.3%) of N2 worms being paralyzed by the end of the experiment (Fig 7A: orange line). The N2’s lost their stereotypical sinusoidal wave phenotype (Fig 7B). With ACR-23 being responsible for betaine mediated signaling in C. elegans, we hypothesized that β-alanine betaine would act on similar nAChRs. We exposed acr-23(ok2804) nulls to 50 mM β-alanine betaine and observed reduced paralysis compared to N2, with only 19% (± 4.4%) of animals being paralyzed after 2 hours (Fig 7A: red line). Unlike N2, acr-23 nulls still maintained the sinusoidal waveform (Fig 7C). We repeated the experiments using 50 mM betaine and saw no evidence of larval arrest or animal paralysis like previous publications [7,10] (S5 Fig). These results suggest that β-alanine betaine paralyzes C. elegans with effects mediated via ACR-23 receptors.
A: Motility assay on 50 mM β-alanine betaine with wild-type N2 C. elegans (Orange), acr-23 (red), acr-20 (blue), deg-3/des-2 (green) and lgc-41 (pink). n = 30 worms for each genotype, 3 replicates. All values represented as means ± SEM. B: Photograph of N2 after 2 hours on 50 mM β-alanine betaine. Note the lack of sinusoidal wave. C: Photograph of acr-23 after 2 hours on 50 mM β-alanine betaine. Note the presence of body bends in the worm.
We then treated other C. elegans null mutants of the betaine receptors on our β-alanine betaine plates. Fig 7A shows the effects of 50 mM β-alanine betaine on acr-20 (ok1849), deg-3 (u662)/des-2 (u695) double mutants and lgc-41(sy1495) null mutants. Over the 2-hour period, β-alanine betaine affected the nulls differently: the most resistant worms were the acr-20 null mutants, (Fig 7A: blue line). Only 25% (± 3.3) of the acr-20 nulls were paralyzed after 2 hours, a result like the acr-23 null mutants. Both the acr-20 nulls and acr-23 nulls were still capable of body bends. The DEG-3/DES-2 (u662/u695) double mutant was less resistant to β-alanine betaine compared to acr-23 and acr-20, with 35% (± 5.8%) of worms being paralyzed after two hours (Fig 7A: green line). The lgc-41 mutants were even less resistant with 45% (± 5.8%) of worms being paralyzed (Fig 7A: pink line), after 2 hours. Our results suggest that β-alanine betaine could act on the ACR-23 and ACR-20 receptors but also less potently on the DEG-3/DES-2 heteromeric receptors and LGC-41 receptors.
Discussion
There are a surprising number of nAChR subunit genes in nematodes with ~32 annotated nAChRs in C. elegans that have been divided into five subfamilies: 1) the UNC-29 subfamily, 2) the UNC-38 subfamily, 3) the ACR-8 subfamily, 4) the ACR-16 subfamily, and 5) the DEG-3/DES-2 subfamily [2]. The DEG-3/DES-2 subfamily group are interesting because some of their nAChRs have been activated by the anthelmintic monepantel, betaine and/or choline [6]. We wondered if there could be additional unrecognized endogenous cholinergic ligands present in nematodes that were selective for these different nAChRs.
We detected β-alanine betaine, but not betaine, in the pseudocoelomic fluid of A. suum as well as mRNA for members of the DEG-3/DES-2 nAChR subfamily in the body wall and intestine. Injection of β-alanine betaine produced a characteristic ‘pretzel’ coiling paralysis. Application of β-alanine betaine to the Ascaris intestine produced a clear Ca2+ signal and depolarized body wall muscle. Finally, C. elegans acr-20, acr-23, deg-3/des-2 and lgc-41 mutants were less sensitive to the paralytic effects of β-alanine betaine. These observations suggest that β-alanine betaine can serve as an endogenous ligand for some members of the DEG-3/DES-2 nAChR subfamily in A. suum.
Betaine in aerobic and β-alanine betaine in anaerobic environments
Betaine may be produced by oxidation of choline or be taken up from the environment: in C. elegans choline is first oxidized to betaine aldehyde by choline dehydrogenase and then to betaine, by betaine aldehyde dehydrogenase [7]. Betaine can also be taken up from the environment by a high-affinity transporter SNF-3 [7]. In parasitic nematodes, betaine has been found to be present in H. contortus, N. americanus and N. brasiliensis [17,19,20].
We found β-alanine betaine but no betaine in adult A. suum which live in a low oxygen environment in the host pig intestine. In hypoxic plants [26], β-alanine betaine is synthesized from β-alanine via methyltransferases: β-alanine is methylated to N-methyl β-alanine, then methylated again to N-N-dimethyl β-alanine and then again to β-alanine betaine. This pathway relies exclusively on methyltransferases and is independent of oxygen, in contrast to choline oxidation pathways required for betaine synthesis. β-alanine betaine is preferentially accumulated in organisms adapted to high saline and hypoxic or anaerobic conditions [27]. Thus, it is possible that A. suum in its anaerobic environment produces β-alanine betaine rather than betaine as an endogenous ligand.
Ion-channels activated by betaine and choline in C. elegans and H. contortus
Choline and betaine have been reported in C. elegans [22,28]. Both choline and betaine serve different functions, including acting as osmolytes, and as endogenous ligands of nAChRs. Choline and betaine selectively activate nematode members of the DEG-3/DES-2 subfamily of nAChR ion-channels. Expressed C. elegans ACR-23 homomeric nAChR channels are activated by betaine (EC50 = 1.4 mM) but not choline or ACh [7]. C. elegans ACR-20 homomeric nAChR channels are selectively activated by betaine (EC50 ~ 25 µM), less by choline (EC50 ~ 1.2 mM) and hardly at all by ACh [8]. C. elegans DEG-3/DES-2 channels are activated by betaine (EC50 ~ 0.6 mM) and less potently by choline (EC50 ~ 1.8 mM) [9]. Betaine is more potent than choline and ACh on these C. elegans channels. β-alanine betaine has not yet been tested on expressed nAChR channels.
Betaine is also found in H. contortus [19]. Studies of H. contortus expressed MPTL-1 channels (formally referred to as Hc-ACR-23-H) found that betaine (EC50 = 41 µM) activates these channels, and that choline (EC50 = 1.3 mM) is less potent [8]. Rufener et al. [29] studied effects of ACh and choline on expressed H. contortus DEG-3/DES-2 channels and found that choline had an EC50 of 10 mM, but that ACh was a poor agonist even at 10 mM; the effects of betaine on this nAChR were not studied.
Although we found signals for ACh, choline, and β-alanine betaine in pseudocoelomic fluid of A. suum, we did not find betaine. Betaine is produced by oxidation of choline and requires an aerobic environment; the absence of betaine and the presence of β-alanine betaine in A. suum may be explained by its anaerobic environment and that β-alanine betaine is produced anaerobically [26,27]. Thus, if betaine functions as both an osmolyte and an endogenous ligand in aerobic nematodes, β-alanine betaine may fulfill analogous roles in anaerobic species such as A. suum.
Effects of monepantel illustrate the therapeutic significance of the DEG-3/DES-2 subfamily
Monepantel (an ADD: amino-acetonitrile derivative) is active against nematode parasites of ruminants including H. contortus, Trichostrongylus colubriformis, Nematodirus spathiger, Cooperia oncophora and Teladorsagia circumcincta. Monepantel also inhibits movement of C. elegans by causing hypercontraction of the body wall and anterior pharynx. This hypercontraction is mediated in part by acr-23 nAChRs because C. elegans null-mutants are resistant to ADDs [6]. Furthermore, monepantel is a type 2 positive allosteric modulator (PAM) on members of the DEG-3/DES-2 subfamily [7]. Combinations of monepantel and betaine positively modulate signals in C. elegans via ACR-23, ACR-20 and in the H. contortus channel MPTL-1 [7], but has no PAM effect on betaine signaling on the DEG-3/DES-2 channels [9]. Monepantel is not effective against A. suum infections, but is a non-competitive antagonist of ACR-16’s and on the levamisole and pyrantel nAChRs [30]. Even high concentrations (10 µM) of monepantel do not produce contraction of A. suum body flaps.
β-alanine betaine as an endogenous ligand in A. suum
Betaine activates members of the DEG-3/DES-2 subfamily in aerobic nematodes. In the absence of detected betaine, we suggest that β-alanine betaine may substitute functionally for betaine in A. suum to activate members of the DEG-3/DES-2 subfamily. This view is supported by: 1) the absence of betaine and presence of β-alanine betaine in the pseudocoelomic fluid in A. suum; 2) the absence of an effect of betaine and the pretzel effects of β-alanine betaine following injection in A. suum; 3) the increase in cytoplasmic Ca2+ in enterocytes following application of β-alanine betaine; 4) the depolarizing effects of β-alanine betaine on A. suum somatic muscle cells; and 5) the presence of Asu-acr-20, Asu-acr-23, Asu-deg-3, Asu-des-2, and Asu-lgc41 in the body wall and intestine enterocytes. We point out however that the aerobic C. elegans null mutants of acr-20 (ok1849), acr-23 (ok 2804), deg-3 (u662)/des-2 (u695) and lgc-41(sy1494) were resistant to β-alanine betaine which suggests that the DEG-3/DES-2 subfamily in C. elegans is also sensitive to β-alanine betaine.
Conclusion
Nematodes have multiple subfamilies of nAChRs. We have identified β-alanine betaine in addition to ACh and choline in A. suum. We found evidence that β-alanine betaine can act on the DEG-3/DES-2 subfamily of nAChRs. Multiple subfamilies of nAChRs and multiple endogenous cholinergic ligands permit an increase in behavioral complexity, including movement. Given that the DEG-3/DES-2 subfamily of nAChRs is not present in mammals, it also provides opportunities for the development of selective anthelmintics.
Financial disclosure
This study was supported by NIH NIAID Grants R01AI047194, R01AI155413, to RJM, the EA Benbrook Endowed Chair of Pathology and Parasitology and by ISU CVM Seed Grant funding from the Dr Stephen G. Juelsgaard Dean’s award to PDW from Iowa State College of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PDW received salary from the R01AI155413, NIH NIAID Grant.
Supporting information
S1 Fig. Chromatograms and HPLC-MS showing signals for acetylcholine.
A: Chromatogram from A. suum pseudocoelomic fluid for suspected acetylcholine. B: Chromatogram for acetylcholine neat chemical standard. C: Full scan mass spectrum for suspected acetylcholine from A. suum pseudocoelomic fluid. D: Full scan mass spectrum for mixed acetylcholine standard neat chemical standard. Note the similar retention time of 4.37min for the pseudocoelomic fluid and 4.41 min for the acetylcholine neat standard. The m/z 146.1173 for the HPLC-MS corresponds to the mass signal for acetylcholine. This data demonstrates signals consistent with acetylcholine but is not as definitive as MS/MS spectra
https://doi.org/10.1371/journal.pntd.0014518.s001
(TIF)
S2 Fig. Chromatograms and HILIC–MS/MS showing signals for choline.
A: Chromatogram from A. suum pseudocoelomic fluid for suspected choline. B: Chromatogram for choline neat chemical standard. C: MS/MS spectrum for suspected choline from A. suum pseudocoelomic fluid. D: MS/MS spectrum for choline neat chemical standard. Note the retention time on 3.15 min of a peak for the pseudocoelomic fluid for and 3.16min for the neat chemical standard. Also note the peaks at 45.03, 58.06, 60.08, and 104.10 m/z for the pseudocoelomic fluid and the choline neat standard.
https://doi.org/10.1371/journal.pntd.0014518.s002
(TIF)
S3 Fig. Protein alignment of Cel-ACR-23 and Asu-ACR-23.
Protein alignment between Cel-ACR-23 and Asu-ACR-23. The Cel-ACR-23 protein sequence was obtained from wormbase.org and was blasted against the A. suum genome (PRJNA62057) and identified the gene AgR001_g108 as the acr-23 orthologue. Using Clustal Omega we aligned the two proteins obtaining a 53.6% similarity between the protein sequences.
https://doi.org/10.1371/journal.pntd.0014518.s003
(TIF)
S4 Fig. Sanger sequencing of our ACR-23 against genome of A. suum.
To ensure that we successfully targeted Asu-acr-23 we performed full length sequencing of the AgR001_g108 from our cDNA pools using Sanger sequencing and compared our results to the database and obtained 99.8% sequence similarity
https://doi.org/10.1371/journal.pntd.0014518.s004
(TIF)
S5 Fig. Betaine fails to paralyze N2 and acr-23-null C. elegans.
Betaine (50mM) fails to affect the % motility of C. elegans of N2 and acr-23-null (ok2804) worms. 3 experiments were conducted on 10 worms for each experiment (30 worms) for each data point. Values are means. No worms were paralyzed so there was no SEM.
https://doi.org/10.1371/journal.pntd.0014518.s005
(TIF)
S1 Raw Gel. Original Uncropped and Unedited pictures of RT-PCR analysis of Asu-acr-23, acr-20, des-2, deg-3 and lgc-41 presented in Fig 4.
A: paired body wall from A. suum. B: intestine from female A. suum. Each lane represents one of the genes for the body wall or intestine from an individual female worm. Cb = Asu-gapdh as a positive control. NC = negative control where no cDNA template was present. L = FastRuler. Middle Range DNA Ladder (ThermoFisher Scientific). Numbers above labels indicate order in which samples were loaded into the gel. All images were captured using an Azure 600 imaging system.
https://doi.org/10.1371/journal.pntd.0014518.s006
(TIF)
References
- 1. WHO. Soil-transmitted helminth infections. 2023. https://www.who.int/news-room/fact-sheets/detail/soil-transmitted-helminth-infections
- 2. Jones AK, Davis P, Hodgkin J, Sattelle DB. The nicotinic acetylcholine receptor gene family of the nematode Caenorhabditis elegans: an update on nomenclature. Invert Neurosci. 2007;7(2):129–31. pmid:17503100
- 3. Wolstenholme AJ, Neveu C. The interactions of anthelmintic drugs with nicotinic receptors in parasitic nematodes. Emerg Top Life Sci. 2017;1(6):667–73. pmid:33525839
- 4. Buxton SK, Charvet CL, Neveu C, Cabaret J, Cortet J, Peineau N, et al. Investigation of acetylcholine receptor diversity in a nematode parasite leads to characterization of tribendimidine- and derquantel-sensitive nAChRs. PLoS Pathog. 2014;10(1):e1003870. pmid:24497826
- 5. Holden-Dye L, Joyner M, O’Connor V, Walker RJ. Nicotinic acetylcholine receptors: a comparison of the nAChRs of Caenorhabditis elegans and parasitic nematodes. Parasitol Int. 2013;62(6):606–15. pmid:23500392
- 6. Kaminsky R, Ducray P, Jung M, Clover R, Rufener L, Bouvier J, et al. A new class of anthelmintics effective against drug-resistant nematodes. Nature. 2008;452(7184):176–80. pmid:18337814
- 7. Peden AS, Mac P, Fei Y-J, Castro C, Jiang G, Murfitt KJ, et al. Betaine acts on a ligand-gated ion channel in the nervous system of the nematode C. elegans. Nat Neurosci. 2013;16(12):1794–801. pmid:24212673
- 8. Baur R, Beech R, Sigel E, Rufener L. Monepantel irreversibly binds to and opens Haemonchus contortus MPTL-1 and Caenorhabditis elegans ACR-20 receptors. Mol Pharmacol. 2015;87(1):96–102. pmid:25352042
- 9. Hansen TVA, Sager H, Toutain CE, Courtot E, Neveu C, Charvet CL. The Caenorhabditis elegans DEG-3/DES-2 channel is a betaine-gated receptor insensitive to monepantel. Molecules. 2022;27(1):312.
- 10. Hardege I, Morud J, Yu J, Wilson TS, Schroeder FC, Schafer WR. Neuronally produced betaine acts via a ligand-gated ion channel to control behavioral states. Proc Natl Acad Sci U S A. 2022;119(48):e2201783119. pmid:36413500
- 11. Stiernagle T. Maintenance of C. elegans. WormBook. 2006;:1–11. pmid:18050451
- 12. Martin RJ. The gamma-aminobutyric acid receptor of Ascaris as a target for anthelmintics. Biochem Soc Trans. 1987;15(1):61–5. pmid:3030844
- 13. Williams PDE, Kashyap SS, Robertson AP, Martin RJ. Diethylcarbamazine elicits Ca2+ signals through TRP-2 channels that are potentiated by emodepside in Brugia malayi muscles. Antimicrob Agents Chemother. 2023;67(10):e0041923. pmid:37728916
- 14. Vasudevamurthy MK, Lever M, George PM, Morison KR. Betaine structure and the presence of hydroxyl groups alters the effects on DNA melting temperatures. Biopolymers. 2009;91(1):85–94. pmid:18781629
- 15. Mellanby H. The identification and estimation of acetylcholine in three parasitic nematodes (Ascaris lumbricoides, Litomosoides carinii, and the microfilariae of Dirofilaria repens). Parasitology. 1955;45(3–4):287–94. pmid:13280270
- 16. Brendza KM, Haakenson W, Cahoon RE, Hicks LM, Palavalli LH, Chiapelli BJ, et al. Phosphoethanolamine N-methyltransferase (PMT-1) catalyses the first reaction of a new pathway for phosphocholine biosynthesis in Caenorhabditis elegans. Biochem J. 2007;404(3):439–48. pmid:17313371
- 17. Wangchuk P, Yeshi K, Loukas A. Metabolomics and lipidomics studies of parasitic helminths: molecular diversity and identification levels achieved by using different characterisation tools. Metabolomics. 2023;19(7):63. pmid:37356029
- 18. Lan W, Xiao X, Nian J, Wang Z, Zhang X, Wu Y, et al. Senolytics enhance the longevity of Caenorhabditis elegans by altering betaine metabolism. J Gerontol A Biol Sci Med Sci. 2024;79(11):glae221. pmid:39434620
- 19. Pelantová H, Šadibolová M, Žofka M, Matoušková P, Luzarowski M, Krátký J, et al. Metabolomic and proteomic differences in susceptible and benzimidazole-resistant adult females and males of Haemonchus contortus. Vet Res. 2025;57(1):17. pmid:41437124
- 20. Yeshi K, Creek DJ, Anderson D, Ritmejerytė E, Becker L, Loukas A, et al. Metabolomes and lipidomes of the infective stages of the gastrointestinal nematodes. Metabolites. 2020;10(11). pmid:33171998
- 21. Martin RJ, Robertson AP, Buxton SK, Beech RN, Charvet CL, Neveu C. Levamisole receptors: a second awakening. Trends Parasitol. 2012;28(7):289–96. pmid:22607692
- 22. Liu F, Li T, Gong H, Tian F, Bai Y, Wang H, et al. Structural insights into the molecular effects of the anthelmintics monepantel and betaine on the Caenorhabditis elegans acetylcholine receptor ACR-23. EMBO J. 2024;43(17):3787–806. pmid:39009676
- 23. Rufener L, Bedoni N, Baur R, Rey S, Glauser DA, Bouvier J, et al. Acr-23 encodes a monepantel-sensitive channel in Caenorhabditis elegans. PLoS Pathog. 2013;9(8):e1003524. pmid:23950710
- 24. Xiong H, Pears C, Woollard A. An enhanced C. elegans based platform for toxicity assessment. Sci Rep. 2017;7(1):9839. pmid:28852193
- 25. O’Reilly LP, Luke CJ, Perlmutter DH, Silverman GA, Pak SC. C. elegans in high-throughput drug discovery. Adv Drug Deliv Rev. 2014;69–70:247–53. pmid:24333896
- 26. Parthasarathy A, Savka MA, Hudson AO. The synthesis and role of β-alanine in plants. Front Plant Sci. 2019;10:921. pmid:31379903
- 27. Hanson AD, Rathinasabapathi B, Chamberlin B, Gage DA. Comparative physiological evidence that beta-alanine betaine and choline-o-sulfate act as compatible osmolytes in halophytic limonium species. Plant Physiol. 1991;97(3):1199–205. pmid:16668509
- 28. Wan QL, Shi X, Liu J, Ding AJ, Pu YZ, Li Z. Metabolomic signature associated with reproduction-regulated aging in. Aging (Albany NY). 2017;9(2):447–74. pmid:28177875
- 29. Rufener L, Baur R, Kaminsky R, Mäser P, Sigel E. Monepantel allosterically activates DEG-3/DES-2 channels of the gastrointestinal nematode Haemonchus contortus. Mol Pharmacol. 2010;78(5):895–902. pmid:20679419
- 30. Abongwa M, Marjanovic DS, Tipton JG, Zheng F, Martin RJ, Trailovic SM, et al. Monepantel is a non-competitive antagonist of nicotinic acetylcholine receptors from Ascaris suum and Oesophagostomum dentatum. Int J Parasitol Drugs Drug Resist. 2018;8(1):36–42. pmid:29366967